FORM 12B-25
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
Commission File Number_000-33271
NOTIFICATION OF LATE FILING
(Check One): |X | Form 10-K |_| Form 11-K
|_| Form 20-F |_| Form 10-Q |_| Form N-SAR
For Period Ended: November 30,
2013
|_| Transition Report on Form 10-K
|_| Transition Report on Form 20-F
|_| Transition Report on Form 11-K
|-| Transition Report on Form 10-Q
|_| Transition Report on Form N-SAR
For the Transition Period Ended:____________________________________
Read attached instruction sheet before preparing
form. Please print or type.
Nothing in this form shall be construed to
imply that the Commission has verified any information contained herein.
If the notification relates to a portion of
the filing checked above, identify the item(s) to which the notification relates: ________________________
PART I
REGISTRANT INFORMATION
Purthanol Resources Limited
( formerly Global Biotech Corp.)
2711 Centreville Rd Suite 400
Wilmington, Delaware , 19808
PART II
RULE 12b-25(b) AND (c)
If the subject report could not be
filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be
completed. (Check box if appropriate.)
|X| | (a) The reasons described in reasonable
detail in Part III of this form could not be eliminated without unreasonable effort or expense;
|X| | (b) The subject annual report, semi-annual
report, transition report on Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or before the 15th calendar
day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof will
be filed on or before the fifth calendar day following the prescribed due date; and
| | | (c) the accountant's statement
or other exhibit required by Rule 12b-25(c) has been attached if applicable.
PART III
NARRATIVE
State below in reasonable detail why the Form
10-K, 11-K, 20-F 10-Q, N-SAR or the transition report portion thereof could not be filed within the prescribed time period. (Attach
extra sheets if needed.)
The Registrant was unable to timely file the
Report without unreasonable effort or expense due to delays resulting from a significant change in management personnel.
PART IV
OTHER INFORMATION
(1) Name and telephone
number of person to contact in regard to this notification
Leonard Stella (302) 288-0658
(2) Have all other periodic reports
required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during
the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer
is no, identify report(s).
|X| Yes |_| No
(3) Is it anticipated that any significant
change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements
to be included in the subject report or portion thereof?
|_| Yes |X| No
If so: attach an explanation of
the anticipated change, both narratives and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of
the results cannot be made.
Purthanol Resources Limited
(formerly Global Biotech Corp.)
has caused this notification to be signed
on its behalf, by the undersigned thereunto duly authorized.
Date 03/03/2014
By
/s/ Leonard Stella
INSTRUCTION: The form may be signed by an
executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the
form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to sign on behalf of the registrant shall be filed
with the form.
ATTENTION
Intentional misstatements or omissions
of fact constitute Federal Criminal Violations
(See 18 U.S.C. 1001).
GENERAL INSTRUCTIONS
1. This form is required by Rule
12b-25 of the General Rules and Regulations under the Securities Exchange Act of 1934.
2. One signed original and four
conformed copies of this form and amendments thereto must be completed and filed with the Securities and Exchange Commission, Washington,
DC 20549, in accordance with Rule 0-3 of the General Rules and Regulations under the Act. The information contained in or filed
with the form will be made a matter of public record in the Commission files.
3. A manually signed copy of the
form and amendments thereto shall be filed with each national securities exchange on which any class of securities of the registrant
is registered.
4. Amendments to the notifications
must also be filed on Form 12b-25 but need not restate information that has been correctly furnished. The form shall be clearly
identified as an amended notification.
5. Electronic Filers. This form
shall not be used by electronic filers unable to timely file a report solely due to electronic difficulties. Filers unable to submit
a report within the time period prescribed due to difficulties in electronic filing should comply with either Rule 201 or Rule
202 of Regulation S-T or apply for an adjustment in filing date pursuant to Rule 13(b) of Regulation S-T.
Purthanol Resources (CE) (USOTC:PURT)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Purthanol Resources (CE) (USOTC:PURT)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024
